At ARHI, we champion the role of responsible private capital investment in enhancing healthcare accessibility, quality, and innovation. Our mission is to foster a nuanced and evidence-based dialogue around the impact of these investments on communities nationwide.
Who We Are
Private capital plays a crucial role in enhancing healthcare access and innovation. By investing in healthcare, we drive advancements that benefit communities. Our commitment is to ensure that every investment adheres to critical standards and fosters positive change in the healthcare landscape.
Provides needed funds to discover and commercialize new treatments and technologies to improve the health of Americans.
Invests in healthcare systems to ensure the continued delivery of affordable, accessible, and sustainable health services in local communities.
Builds medical practices that streamline requirements so healthcare professionals can focus on patients and operate independently from conglomerates.
What We Are Doing
We are committed to expanding access to healthcare services across diverse communities. By investing in innovative solutions, we aim to bridge the gap in care availability. Our focus is on fostering a healthier future for all.
Our investments grant more opportunities for individuals of all income levels to receive life-changing care and promote healthier long-term lifestyle choices.
Through private capital’s continued investment, we are developing cutting-edge technologies that will greatly improve patient outcomes.
Private capital investment is critical to chart positive healthcare outcomes across rural and urban communities of all sizes. These investments ensure equitable access to healthcare for all individuals within varied localities.
News
Explore the latest in healthcare investment news.
Nationally, and in Oregon, there is an ongoing debate about the role of private capital investment in our healthcare system.
Private capital can assist early-stage companies, as well as university research centers developing health products, to connect with large-scale drug companies to get through the regulatory process and bring their products to market.
Submitted by Regan Parker, CEO, Association for Responsible Healthcare Investment (ARHI)
Texas House Public Health Committee | April 2025